A Study Evaluating the Safety of VX-152 Combination Therapy in Adults With Cystic Fibrosis
Clinical trial NCT02951195 · COMPLETED
Trial details
- NCT number
- NCT02951195
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2018-01-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.